0001209191-14-066728.txt : 20141105
0001209191-14-066728.hdr.sgml : 20141105
20141105172419
ACCESSION NUMBER: 0001209191-14-066728
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141103
FILED AS OF DATE: 20141105
DATE AS OF CHANGE: 20141105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SACHS BRUCE I
CENTRAL INDEX KEY: 0001197036
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 141197877
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-11-03
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197036
SACHS BRUCE I
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2014-11-03
4
M
0
20000
34.32
A
41210
D
Common Stock
2014-11-03
4
S
0
17316
112.03
D
23894
D
Common Stock
2014-11-03
4
S
0
2684
112.80
D
21210
D
Common Stock
2014-11-04
4
M
0
10000
29.84
A
31210
D
Common Stock
2014-11-04
4
S
0
2300
112.47
D
28910
D
Common Stock
2014-11-04
4
S
0
3200
113.47
D
25710
D
Common Stock
2014-11-04
4
S
0
4400
114.23
D
21310
D
Common Stock
2014-11-04
4
S
0
100
115.45
D
21210
D
Common Stock
2014-11-05
4
M
0
100
29.84
A
21310
D
Common Stock
2014-11-05
4
S
0
100
111.86
D
21210
D
Stock Option (right to buy)
34.32
2014-11-03
4
M
0
20000
0.00
D
2016-05-31
Common Stock
20000
0
D
Stock Option (right to buy)
29.84
2014-11-04
4
M
0
10000
0.00
D
2017-05-31
Common Stock
10000
10000
D
Stock Option (right to buy)
29.84
2014-11-05
4
M
0
100
0.00
D
2017-05-31
Common Stock
100
9900
D
Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.
Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $112.03 (range $111.64 to $112.63).
Open market sales reported on this line occurred at a weighted average price of $112.80 (range $112.64 to $113.24).
Open market sales reported on this line occurred at a weighted average price of $112.47 (range $111.91 to $112.89).
Open market sales reported on this line occurred at a weighted average price of $113.47 (range $112.91 to $113.88).
Open market sales reported on this line occurred at a weighted average price of $114.23 (range $113.95 to $114.71).
Fully vested.
Omar White, Attorney-In-Fact
2014-11-05